OBJECTIVE: The study objective was to examine the relationship between visceral and somatic protein stores and physical activity in individuals with end-stage renal disease. DESIGN: This was a prospective single-center study. SETTING: The study took place at the Vanderbilt University Outpatient Dialysis Unit and General Clinical Research Center. PATIENTS: Fifty-five patients with prevalent chronic hemodialysis (CHD) were included: 33 males, 22 females, 45 African Americans, 9 Caucasians, and 1 Asian. The mean age was 47.0 +/- 1.6 years, height was 166.4 +/- 13.9 cm, and weight was 83.1 +/- 2.6 kg. METHODS: Body composition was measured by dual-energy x-ray absorptiometry. Minute-by-minute physical activity was assessed over a 7-day period with a triaxial accelerometer. Participants were interviewed by a trained registered dietitian for two 24-hour diet recalls (one from a hemodialysis day; one from a nonhemodialysis day). Laboratory values for serum concentrations of albumin, prealbumin, C-reactive protein, and creatinine were also collected. MAIN OUTCOME MEASURE: Predictors of somatic protein stores were the main outcome measure. RESULTS: Serum albumin was negatively and significantly correlated with the percentage of fat mass (P = .016) and kg of fat mass (P = .044). C-reactive protein was positively and significantly correlated with body weight (P = .006), percentage of fat mass (P = .017), kg of fat mass (P = .006), and body mass index (P = .004). Physical activity and total daily protein intake were the strongest predictors of the amount of lean body mass (P = .01 and .003, respectively). CONCLUSION: The association between somatic protein and visceral protein stores is weak in patients with CHD. Whereas increased levels of physical activity and total daily protein intake are associated with higher lean body mass in patients with CHD, higher adiposity is associated with higher C-reactive protein and lower albumin values.
OBJECTIVE: The study objective was to examine the relationship between visceral and somatic protein stores and physical activity in individuals with end-stage renal disease. DESIGN: This was a prospective single-center study. SETTING: The study took place at the Vanderbilt University Outpatient Dialysis Unit and General Clinical Research Center. PATIENTS: Fifty-five patients with prevalent chronic hemodialysis (CHD) were included: 33 males, 22 females, 45 African Americans, 9 Caucasians, and 1 Asian. The mean age was 47.0 +/- 1.6 years, height was 166.4 +/- 13.9 cm, and weight was 83.1 +/- 2.6 kg. METHODS: Body composition was measured by dual-energy x-ray absorptiometry. Minute-by-minute physical activity was assessed over a 7-day period with a triaxial accelerometer. Participants were interviewed by a trained registered dietitian for two 24-hour diet recalls (one from a hemodialysis day; one from a nonhemodialysis day). Laboratory values for serum concentrations of albumin, prealbumin, C-reactive protein, and creatinine were also collected. MAIN OUTCOME MEASURE: Predictors of somatic protein stores were the main outcome measure. RESULTS: Serum albumin was negatively and significantly correlated with the percentage of fat mass (P = .016) and kg of fat mass (P = .044). C-reactive protein was positively and significantly correlated with body weight (P = .006), percentage of fat mass (P = .017), kg of fat mass (P = .006), and body mass index (P = .004). Physical activity and total daily protein intake were the strongest predictors of the amount of lean body mass (P = .01 and .003, respectively). CONCLUSION: The association between somatic protein and visceral protein stores is weak in patients with CHD. Whereas increased levels of physical activity and total daily protein intake are associated with higher lean body mass in patients with CHD, higher adiposity is associated with higher C-reactive protein and lower albumin values.
Authors: Michael V Rocco; Lata Paranandi; Jerrilynn D Burrowes; David B Cockram; Johanna T Dwyer; John W Kusek; June Leung; Rhoda Makoff; Bradley Maroni; Diane Poole Journal: Am J Kidney Dis Date: 2002-02 Impact factor: 8.860
Authors: Kirsten L Johansen; Tiffany Shubert; Julie Doyle; Brian Soher; Giorgos K Sakkas; Jane A Kent-Braun Journal: Kidney Int Date: 2003-01 Impact factor: 10.612
Authors: T Alp Ikizler; Lara B Pupim; John R Brouillette; Deanna K Levenhagen; Kali Farmer; Raymond M Hakim; Paul J Flakoll Journal: Am J Physiol Endocrinol Metab Date: 2002-01 Impact factor: 4.310
Authors: K L Johansen; G M Chertow; A V Ng; K Mulligan; S Carey; P Y Schoenfeld; J A Kent-Braun Journal: Kidney Int Date: 2000-06 Impact factor: 10.612
Authors: Kirsten L Johansen; George A Kaysen; Belinda S Young; Adriana M Hung; Makani da Silva; Glenn M Chertow Journal: Am J Clin Nutr Date: 2003-04 Impact factor: 7.045
Authors: N Takahashi; S Yuasa; M Fukunaga; T Hara; K Moriwaki; T Shokoji; H Hitomi; H Fujioka; H Kiyomoto; Y Aki; M Hirohata; K Mizushige; M Kohno Journal: Clin Nephrol Date: 2003-05 Impact factor: 0.975
Authors: Lara B Pupim; Paul J Flakoll; John R Brouillette; Deanna K Levenhagen; Raymond M Hakim; T Alp Ikizler Journal: J Clin Invest Date: 2002-08 Impact factor: 14.808
Authors: J C Kim; B B Shapiro; M Zhang; Y Li; J Porszasz; R Bross; U Feroze; R Upreti; K Kalantar-Zadeh; J D Kopple Journal: J Cachexia Sarcopenia Muscle Date: 2014-04-29 Impact factor: 12.910